Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Biomarkers and Treatment Response in Atopic Dermatitis
jRCT1040260080Recruiting
- Sponsor
- Fujita Health University
- Start
- Jul 2026
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics, Small Molecules
- Countries
- 1
01
Overview
Open-label trial of upadacitinib, lebrikizumab and corticosteroids in atopic dermatitis (AD) (2 arms), sponsored by Fujita Health University. Started Jul 2026; status: recruiting.
02
Drugs
upadacitiniblebrikizumabcorticosteroids
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on jRCT1040260080.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1040260080.